AI
COLL icon

Atria Investments’s Collegium Pharmaceutical COLL Stock Holding History

Atria Investments’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,201
Closed -$183K – 580
2020
Q1 		$183K Sell
11,201
-9,125
-45% -$188K 0.01% 533
2019
Q4 		$418K Sell
20,326
-2,968
-13% -$49.5K 0.01% 850
2019
Q3 		$267K Buy
23,294
+452
+2% +$5.16K 0.01% 754
2019
Q2 		$260K Buy
22,842
+5,928
+35% +$79.3K 0.01% 798
2019
Q1 		$256K Buy
16,914
+4,772
+39% +$76.4K 0.01% 762
2018
Q4 		$208K Sell
12,142
-3,165
-21% -$54.2K 0.01% 802
2018
Q3 		$226K Buy
15,307
+6,866
+81% +$122K 0.01% 888
2018
Q2 		$201K Buy
+8,441
New +$208K 0.01% 913

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Atria Investments's COLL Position: Q2 2020 in Review

Atria Investments sold out of Collegium Pharmaceutical (COLL) in Q2 2020, closing a stake of 11,201 shares — an estimated $183K sold.

Atria Investments first reported a position in COLL in Q2 2018 and held it in 8 quarters. The position peaked at $418K in Q4 2019. 150 funds tracked by Wall St. Rank hold COLL as of Q2 2020.

  • Atria Investments reported no remaining Collegium Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • Atria Investments sold 11,201 Collegium Pharmaceutical shares in Q2 2020, an estimated $183K.
  • Atria Investments first reported a position in Collegium Pharmaceutical in Q2 2018 and held it in 8 quarters.
  • Atria Investments's Collegium Pharmaceutical position peaked at $418K in Q4 2019.
  • 150 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2020.

Based on Atria Investments's 13F filing for Q2 2020, filed 13 Aug 2020.